HF Best Ideas
AnalysesQuarterly LettersInsightsChartsWarren AI
All funds

Goodhart Partners

Mar 2026 → Sep 2026 · 4 funds

Our archive holds 14 letters from Goodhart Partners, behind 11 investment theses and positions in 37 companies. Every quote below is copied verbatim from the letter it came from.

Writes about

Get an email when this fund publishes its next letter

14
Letters
37
Companies
32
Moves
11
Theses

4 strategies

Goodhart Partners publishes a letter per strategy. Each one has its own page with what it holds, what it bought and what it wrote.

Returns as reported in each strategy’s latest letter, extracted automatically and not verified by us; one share class, in its own currency. Not investment advice. Past performance does not predict future returns.

What they bought and sold · 32 moves

  • ExitedLumine Group Inc.
    September 2026
    “Notable sells - Angi, Intermap and Lumine Group.”
    Read the letter
  • New positionBakkafrost
    September 2026
    “Our one new holding is Bakkafrost, the salmon farmer.”
    Read the letter
  • AddedPDF Solutions
    September 2026
    “We used the weakness: we added to all three over the quarter.”
    Read the letter
  • ExitedPinewood Technologies Group plc
    September 2026
    “We also sold Pinewood Technologies, which received a takeover bid.”
    Read the letter
  • ExitedIntermap Technologies Corporation
    September 2026
    “Notable sells - Angi, Intermap and Lumine Group.”
    Read the letter
  • AddedACM Research
    September 2026
    “We used the weakness: we added to all three over the quarter.”
    Read the letter
  • ExitedGQG Partners Inc.
    September 2026
    “We sold GQG Partners because the investment thesis changed and my waypoints weren’t hit.”
    Read the letter
  • AddedASML
    September 2026
    “We used the weakness: we added to all three over the quarter.”
    Read the letter
  • ExitedAngi Inc.
    September 2026
    “Notable sells  - Angi, Intermap and Lumine Group.”
    Read the letter
  • New positionGTT
    September 2026
    “Koninklijke Philips (“Philips”) was sold in favour of increasing exposure to GTT, in which the Fund initiated a position the preceding quarter.”
    Read the letter
  • AddedSoitec
    September 2026
    “We added heavily in February at around €31, after meeting management and concluding that the fundamentals were closer to turning than the share price implied.”
    Read the letter
  • ExitedKoninklijke Philips
    September 2026
    “Koninklijke Philips (“Philips”) was sold in favour of increasing exposure to GTT, in which the Fund initiated a position the preceding quarter.”
    Read the letter
  • ExitedGQG Partners
    September 2026
    “We exited two positions: GQG Partners”
    Read the letter
  • ExitedEnovis
    September 2026
    “Enovis was a mistake, and we sold at a loss of around 22%.”
    Read the letter
  • New positionScout24
    June 2026
    “Other new positions are Wolters Kluwer, Bonesupport, Raysearch and Scout24 which are not really AI losers in our view but have been hit on that basis during the SaaS apocalypse.”
    Read the letter
  • ExitedSoitec
    June 2026
    “I trimmed meaningfully and sold the remainder at EUR150 as I could no longer justify the returns within my multi-bagger framework”
    Read the letter
  • TrimmedTasmea Limited
    June 2026
    “I trimmed twice, both times a mistake.”
    Read the letter
  • New positionRheinmetall
    June 2026
    “We bought Rheinmetall after a halving of the share price culminating in a 20% fall in the loss of a frigate contract.”
    Read the letter
  • New positionAG Barr
    June 2026
    “AG Barr was added to the portfolio as a Resilient stock.”
    Read the letter
  • TrimmedAngi
    June 2026
    “Angi, -50%, a small position and subsequently sold due to a change in thesis”
    Read the letter
  • New positionGaztransport et Technigaz
    June 2026
    “Elsewhere we have added a position in Gaztransport et Technigaz (16x FY1 PE), who have a global monopoly on LNG membranes on the basis demand is likely to remain robust, and the new management can develop a sizable service and aftermarket business from its current low level.”
    Read the letter
  • New positionRaySearch
    June 2026
    “Other new positions are Wolters Kluwer, Bonesupport, Raysearch and Scout24 which are not really AI losers in our view but have been hit on that basis during the SaaS apocalypse.”
    Read the letter
  • ExitedAngi Inc.
    June 2026
    “with only one material downgrade (Angi, −50%, a small position and subsequently sold due to a change in thesis).”
    Read the letter
  • ExitedAlibaba Group
    June 2026
    “selling Alibaba could be a mistake.”
    Read the letter
  • New positionWolters Kluwer
    June 2026
    “Other new positions are Wolters Kluwer, Bonesupport, Raysearch and Scout24 which are not really AI losers in our view but have been hit on that basis during the SaaS apocalypse.”
    Read the letter
  • ExitedSanuwave Health, Inc.
    June 2026
    “I sold with shares down 10% on the day and 30% from purchase.”
    Read the letter
  • AddedSoitec
    June 2026
    “We wrote last quarter that we had increased our position following meetings with management, sensing the fundamentals were closer to turning than the share price implied.”
    Read the letter
  • New positionKatakura Industries
    June 2026
    “When we first looked at Katakura 16 years ago it was a traditional low quality but profitable Japanese conglomerate that owned a frankly ridiculous amount of undeveloped land for legacy reasons.”
    Read the letter
  • New positionams-OSRAM
    June 2026
    “Alongside Soitec and ASML, we have built new positions in ACM Research and ams-OSRAM this quarter, adding to our existing holding in PDF Solutions since launch.”
    Read the letter
  • New positionBoneSupport
    June 2026
    “Other new positions are Wolters Kluwer, Bonesupport, Raysearch and Scout24 which are not really AI losers in our view but have been hit on that basis during the SaaS apocalypse.”
    Read the letter

Showing the 30 most recent of 32 recorded moves.

Companies held · 37

Every company Goodhart Partners has disclosed a position in across our archive, with the letter that last mentioned it.

Theses · 11

  • Veeva Systems
    September 2026

    Veeva Systems is seen as a large holding benefiting from the early innings of the application era, with earnings rising faster than the share price had reflected.

    Read the full thesis
  • DexCom
    September 2026

    DexCom is viewed as a long-term healthcare opportunity expanding from type 1 diabetes into much larger type 2 and wellness markets.

    Read the full thesis
  • Bakkafrost
    September 2026

    Bakkafrost is a new holding based on rising salmon prices, strong demand growth, constrained supply, and an exceptional asset base with Scotland franchise potential.

    Read the full thesis
  • ams-OSRAM
    June 2026

    ams-OSRAM is viewed as a mid-cap semiconductor value-chain business with idiosyncratic drivers and resilience to the broader capex cycle.

    Read the full thesis
  • Bakkafrost
    June 2026

    Bakkafrost is expected to benefit from a Scotland recovery, ending one-off salmon supply pressure, structurally growing salmon demand, and potential El Nino-related supply disruption.

    Read the full thesis
  • Katakura Industries
    June 2026

    Katakura Industries is a deep-value Japanese property and conglomerate play with a fortress balance sheet, valuable assets, and a large discount to NAV.

    Read the full thesis
  • AG Barr
    June 2026

    AG Barr is a Scottish drinks company with improving growth ambitions, cost savings from capex, and a low valuation supporting attractive earnings growth.

    Read the full thesis
  • Rheinmetall
    June 2026

    Rheinmetall is a German defense prime with a strong strategic position, benefiting from Germany’s rearmament and an overdone share price sell-off.

    Read the full thesis
  • Bonesupport
    March 2026

    Bonesupport is an orthobiologics company with a differentiated injectable bioceramic and long-term growth potential at a more acceptable valuation.

    Read the full thesis
  • RaySearch Laboratories
    March 2026

    RaySearch Laboratories is a radiotherapy software company with durable relevance and long-term growth now available at a more attractive price.

    Read the full thesis
  • Diageo
    March 2026

    Diageo is a premium spirits company with attractive long-term emerging-market growth and an appealing valuation.

    Read the full thesis

Letter archive · 14

2026

Get Goodhart Partners’s next letter the day it lands

We track Goodhart Partners alongside hundreds of other managers, read every letter, and pull out what they bought and sold. Warren AI reads the whole archive for you.

View plans→
Share this fund